Alzheimer's disease adjuvant therapy system based on VR (virtual reality) technology and physiological sign monitoring

Abstract

The invention discloses an Alzheimer's disease adjuvant therapy system based on a VR (virtual reality) technology and physiological sign monitoring. The system comprises a data acquisition module, a VR module and a data processing and control module. The data acquisition module is in charge of acquiring physiological sign data of a user; the VR module is in charge of presenting therapy contents of special design to the user; and the data processing and control module is in charge of processing the data and controlling operations of the various modules. By virtue of the VR module, the immersive therapy contents are provided to the user, so as to complete adjuvant rehabilitation therapy on the memory of a patient with early Alzheimer's disease without the direct intervention of doctors or medicines. Through the VR technology, the user can be immersed in the therapy contents of the special design, guided by a big data technology possessing user's historical data and population data, the therapy contents are adjusted in accordance with the physiological sign data of the user; and through such repetition, individual and targeted therapy contents can be provided to the user, so as to promote the rapid rehabilitation of the user.

Description

technical field [0001] The invention relates to the technology of auxiliary treatment equipment for senile dementia, in particular to an auxiliary treatment system for senile dementia based on VR technology and physiological sign monitoring. Background technique [0002] Data show that in my country, Alzheimer's disease is called "senile dementia", with about 10 million people suffering from it, and an average of 300,000 new cases every year. There are tens of millions of families with elderly people with dementia in China, and behind every elderly person with dementia is an overwhelmed family. Suffering from this disease is like a great change that tests the human mind. [0003] At present, the treatment of Alzheimer's disease is generally drug treatment, such as anti-anxiety drugs, antidepressants, antipsychotic drugs, nootropic drugs and drugs to improve cognitive function, etc. treat. Existing drugs can improve symptoms at the early stage of the disease, but can only s...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment of Alzheimer's disease is generally drug treatment, such as anti-anxiety drugs, antidepressants, antipsychotic drugs, nootropic drugs and drugs to improve cognitive function, etc. treat

Existing drugs, in the early stages of the disease, drugs can improve symptoms, can only slightly improve the quality of life of patients, and cannot prevent the development of Alzheimer's disease

With the development of the disease, after long-term use, the patient will feel that the effective time of the drug will be shortened. Once the drug is stopped, the condition will worsen, and it will also have side effects on the patient's body.

Images